Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus.

about

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus.

Item

http://www.wikidata.org/entity/Q35771368

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@ast

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@en

type

Item

label

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@ast

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@en

prefLabel

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@ast

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@en

P1476

Daptomycin approved in Japan f ...... sistant Staphylococcus aureus.

@en

P2093

Hiroshige Mikamo

http://www.w3.org/2001/XMLSchema#string

Mao Hagihara

http://www.w3.org/2001/XMLSchema#string

Takeshi Mori

http://www.w3.org/2001/XMLSchema#string

Takumi Umemura

http://www.w3.org/2001/XMLSchema#string

P2860

Teicoplanin versus vancomycin for proven or suspected infection

Teicoplanin metabolism in humans

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.

Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio

P304

79-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S23875

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221864706

http://www.w3.org/2001/XMLSchema#string

P698

22368449

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

3284219

http://www.w3.org/2001/XMLSchema#string